These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29020849)

  • 1. Microfluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetration.
    Dong YD; Tchung E; Nowell C; Kaga S; Leong N; Mehta D; Kaminskas LM; Boyd BJ
    J Liposome Res; 2019 Mar; 29(1):1-9. PubMed ID: 29020849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid scale-up and production of active-loaded PEGylated liposomes.
    Roces CB; Port EC; Daskalakis NN; Watts JA; Aylott JW; Halbert GW; Perrie Y
    Int J Pharm; 2020 Aug; 586():119566. PubMed ID: 32622812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy.
    Griffin JI; Wang G; Smith WJ; Vu VP; Scheinman R; Stitch D; Moldovan R; Moghimi SM; Simberg D
    ACS Nano; 2017 Nov; 11(11):11584-11593. PubMed ID: 29045127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization.
    Nie Y; Ji L; Ding H; Xie L; Li L; He B; Wu Y; Gu Z
    Theranostics; 2012; 2(11):1092-103. PubMed ID: 23227125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel microfluidic-based approach to formulate size-tuneable large unilamellar cationic liposomes: Formulation, cellular uptake and biodistribution investigations.
    Lou G; Anderluzzi G; Woods S; Roberts CW; Perrie Y
    Eur J Pharm Biopharm; 2019 Oct; 143():51-60. PubMed ID: 31445156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
    Ahmed KS; Shan X; Mao J; Qiu L; Chen J
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent.
    Lozano N; Al-Ahmady ZS; Beziere NS; Ntziachristos V; Kostarelos K
    Int J Pharm; 2015 Mar; 482(1-2):2-10. PubMed ID: 25445515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx
    Burade V; Bhowmick S; Maiti K; Zalawadia R; Jain D; Rajamannar T
    Cancer Chemother Pharmacol; 2017 May; 79(5):899-913. PubMed ID: 28349166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Microfluidic Platform for Evaluating the Internalization of Liposome Drug Carriers in Tumor Spheroids.
    Yakavets I; Ayachit M; Kheiri S; Chen Z; Rakhshani F; McWhirter S; Young EWK; Walker GC; Kumacheva E
    ACS Appl Mater Interfaces; 2024 Feb; 16(8):9690-9701. PubMed ID: 38357740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms.
    Andar AU; Hood RR; Vreeland WN; Devoe DL; Swaan PW
    Pharm Res; 2014 Feb; 31(2):401-13. PubMed ID: 24092051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
    Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
    Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer.
    Charrois GJ; Allen TM
    Biochim Biophys Acta; 2004 May; 1663(1-2):167-77. PubMed ID: 15157619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterically stabilized liposomes production using staggered herringbone micromixer: Effect of lipid composition and PEG-lipid content.
    Cheung CCL; Al-Jamal WT
    Int J Pharm; 2019 Jul; 566():687-696. PubMed ID: 31212051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment.
    Peng PC; Hong RL; Tsai YJ; Li PT; Tsai T; Chen CT
    Lasers Surg Med; 2015 Jan; 47(1):77-87. PubMed ID: 25559348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Delivery of Hispolon and Doxorubicin Liposomes Improves Efficacy Against Melanoma Cells.
    Al Saqr A; Aldawsari MF; Alrbyawi H; Poudel I; Annaji M; Mulabagal V; Ramani MV; Gottumukkala S; Tiwari AK; Dhanasekaran M; Panizzi PR; Arnold RD; Babu RJ
    AAPS PharmSciTech; 2020 Nov; 21(8):304. PubMed ID: 33150503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of EDTA in drug delivery systems: doxorubicin liposomes loaded via NH4EDTA gradient.
    Song Y; Huang Z; Song Y; Tian Q; Liu X; She Z; Jiao J; Lu E; Deng Y
    Int J Nanomedicine; 2014; 9():3611-21. PubMed ID: 25120359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic directed formation of liposomes of controlled size.
    Jahn A; Vreeland WN; DeVoe DL; Locascio LE; Gaitan M
    Langmuir; 2007 May; 23(11):6289-93. PubMed ID: 17451256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.